Home Newsfeeds Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral, Lowers Price Target to $11

Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral, Lowers Price Target to $11

Cantor Fitzgerald analyst Charles Duncan downgrades Anavex Life Sciences (NASDAQ:AVXL) from Overweight to Neutral and lowers the price target from $16 to $11.

byBenzinga Newsdesk

December 6, 2022

1 minute read

Cantor Fitzgerald analyst Charles Duncan downgrades Anavex Life Sciences (NASDAQ:AVXL) from Overweight to Neutral and lowers the price target from $16 to $11.

‘Tim Scott Officially Kicks Off 2024 GOP Presidential Bid’ – Axios

By Benzinga Newsdesk

May 22, 11:46 AM

https://www.axios.com/2023/05/22/tim-scott-2024-presidential-election?utm_medium=social&utm_campaign=editorial&utm_source=twitterSen. Tim Scott (R-S.C.) made his 2024 presidential bid official on Monday, speaking

SPY

New Data Shows Intercept’s Fixed Dose Obeticholic Acid Combo Normalize Multiple Biomarkers In Liver Disease

By Vandana Singh

June 7, 2:20 PM

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) announced initial results from a planned interim analysis of its ongoing Phase 2 study 747-213, an active comparator trial demonstrating the therapeutic potential of the combination of obeticholic acid (OCA) and bezafibrate vs.

ICPT

Barnes & Noble Stock Pops After The Bell: What’s Going On?

By Adam Eckert

June 5, 5:22 PM

Barnes & Noble announced shareholders voted to approve its previously announced equity and refinancing transactions with Immersion Corp and existing shareholders.

BNED

Forget Reddit And Trump Media: Here’s A Less Volatile Way To Cash In On Meme Stocks

By Benzinga Neuro

April 3, 4:49 AM

Investors are exploring alternative ways to profit from meme stocks, such as those popularized by Reddit and Truth Social. These stocks, often linked to social media platforms, have attracted retail investors seeking quick returns.

AFRM

Cantor Fitzgerald Downgrades Anavex Life Sciences to Neutral, Lowers Price Target to $11

Related Posts

‘Tim Scott Officially Kicks Off 2024 GOP Presidential Bid’ – Axios

New Data Shows Intercept’s Fixed Dose Obeticholic Acid Combo Normalize Multiple Biomarkers In Liver Disease

Barnes & Noble Stock Pops After The Bell: What’s Going On?

Forget Reddit And Trump Media: Here’s A Less Volatile Way To Cash In On Meme Stocks